Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Frontotemporal Dementia: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Frontotemporal Dementia is a disease characterized by neurodegeneration research. Key relationships include: interacts with, associated with, activates. Associated with Amyotrophic Lateral Sclerosis, Multisystem Proteinopathy. Connected to 304 entities in the SciDEX knowledge graph.
| Associated Genes | UNC13A, HNRNPA1, HNRNPA2B1, OPTN, SQSTM1, TIA1, VALOSIN, VCP |
| Therapeutic Agents | Disease-Modifying Therapies, Gene Therapy Targeting 14-3-3θ-TDP-43 Interaction, Tdp-43-Targeting Gene Therapy, RNA oligonucleotides |
| KG Connections | 819 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
Knowledge base pages for this entity
graph TD
Frontotemporal_Dementia["Frontotemporal Dementia"] -->|"interacts"| Autophagy["Autophagy"]
Frontotemporal_Dementia["Frontotemporal Dementia"] -->|"regulates"| Oxidative_Stress["Oxidative Stress"]
Frontotemporal_Dementia["Frontotemporal Dementia"] -->|"regulates"| Er_Stress["Er Stress"]
Frontotemporal_Dementia["Frontotemporal Dementia"] -->|"interacts"| Apoptosis["Apoptosis"]
Frontotemporal_Dementia["Frontotemporal Dementia"] -->|"interacts"| Cell_Cycle["Cell Cycle"]
Frontotemporal_Dementia["Frontotemporal Dementia"] -->|"interacts"| Mapk["Mapk"]
ACTB["ACTB"] -->|"interacts"| Frontotemporal_Dementia["Frontotemporal Dementia"]
BECN1["BECN1"] -->|"interacts"| Frontotemporal_Dementia["Frontotemporal Dementia"]
C9ORF72["C9ORF72"] -->|"interacts"| Frontotemporal_Dementia["Frontotemporal Dementia"]
CALCOCO2["CALCOCO2"] -->|"interacts"| Frontotemporal_Dementia["Frontotemporal Dementia"]
style Frontotemporal_Dementia fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Behavioral Disturbances | causes | phenotype | 0.95 |
| Frontal Lobe Neurodegeneration | causes | process | 0.95 |
| Anterior Temporal Lobe Neurodegeneration | causes | process | 0.95 |
| Neurodegeneration | causes | process | 0.95 |
| Brain Atrophy | causes | phenotype | 0.90 |
| Pre-Symptomatic Stage | associated_with | phenotype | 0.90 |
| MAPT | associated_with | gene | 0.85 |
| Anterior Temporal Lobe | expressed_in | cell_type | 0.85 |
| Frontal Lobe | expressed_in | cell_type | 0.85 |
| Movement Disorders | associated_with | disease | 0.85 |
| TARDBP | associated_with | protein | 0.85 |
| Autophagy | interacts_with | pathway | 0.55 |
| Oxidative Stress | regulates | pathway | 0.55 |
| Er Stress | regulates | pathway | 0.55 |
| Apoptosis | interacts_with | pathway | 0.55 |
| Cell Cycle | interacts_with | pathway | 0.55 |
| Mapk | interacts_with | pathway | 0.55 |
| Mitophagy | therapeutic_target | pathway | 0.55 |
| Protein Aggregation | associated_with | pathway | 0.55 |
| Autophagy | activates | pathway | 0.55 |
| Mtor | activates | pathway | 0.55 |
| Proteasome | activates | pathway | 0.55 |
| Ubiquitin-Proteasome | activates | pathway | 0.55 |
| Unfolded Protein Response | activates | pathway | 0.55 |
| Autophagy | associated_with | pathway | 0.55 |
| Mtor | associated_with | pathway | 0.55 |
| Complement | regulates | pathway | 0.55 |
| Amyloid | contributes_to | pathway | 0.55 |
| Mitophagy | interacts_with | pathway | 0.55 |
| Tdp-43 | activates | pathway | 0.55 |
| Tdp-43 | associated_with | pathway | 0.55 |
| Sod1 | inhibits | pathway | 0.55 |
| Sod1 | contributes_to | pathway | 0.55 |
| Tdp-43 | causes | pathway | 0.55 |
| Sod1 | causes | pathway | 0.55 |
| Synaptic Vesicle | interacts_with | pathway | 0.55 |
| Amyloid | biomarker_for | pathway | 0.55 |
| Autophagy | causes | pathway | 0.55 |
| Autophagy | therapeutic_target | pathway | 0.55 |
| Phagocytosis | therapeutic_target | pathway | 0.55 |
| Protein Aggregation | regulates | pathway | 0.55 |
| Akt | causes | pathway | 0.55 |
| Protein Aggregation | activates | pathway | 0.55 |
| Oxidative Stress | activates | pathway | 0.55 |
| Mtor | therapeutic_target | pathway | 0.55 |
| Immune Response | activates | pathway | 0.55 |
| Er Stress | inhibits | pathway | 0.55 |
| Necroptosis | causes | pathway | 0.55 |
| Phagocytosis | activates | pathway | 0.55 |
| Jak-Stat | activates | pathway | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TBK1 | associated_with | gene | 0.95 |
| TDP43 | associated_with | protein | 0.95 |
| C9ORF72 | risk_factor_for | gene | 0.95 |
| TDP-43 | causes | protein | 0.95 |
| TBK1 | risk_factor_for | gene | 0.95 |
| C9orf72 Hexanucleotide Repeat Expansion | causes | biomarker | 0.95 |
| GRN | risk_factor_for | gene | 0.95 |
| MAPT | risk_factor_for | gene | 0.95 |
| Tau | biomarker_for | protein | 0.95 |
| SQSTM1 | biomarker_for | protein | 0.95 |
| Synaptic Dysfunction | contributes_to | phenotype | 0.95 |
| Cerebral Perfusion | biomarker_for | biomarker | 0.92 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.90 |
| Tau Aggregation | associated_with | process | 0.90 |
| Autophagy | involved_in | process | 0.90 |
| TAU | associated_with | protein | 0.90 |
| Innate Immune Activation | contributes_to | process | 0.90 |
| Frontotemporal Phenotype | associated_with | phenotype | 0.90 |
| Innate Immune Activation | associated_with | process | 0.90 |
| UNC13A | risk_factor_for | gene | 0.90 |
| TDP-43 | involved_in | protein | 0.90 |
| Tdp-43-Targeting Gene Therapy | treats | drug | 0.90 |
| STING | associated_with | protein | 0.90 |
| C9ORF72 Hexanucleotide Repeat Expansion | risk_factor_for | biomarker | 0.90 |
| Biomarker | biomarker_for | biomarker | 0.90 |
| Neurodegeneration | involved_in | process | 0.90 |
| CHMP2B | risk_factor_for | gene | 0.90 |
| NOTCH2NLC | associated_with | gene | 0.90 |
| Cryptic Splicing | biomarker_for | process | 0.90 |
| TDP43 | implicated_in | protein | 0.90 |
| CHMP2BIn5 | drives | protein | 0.90 |
| Gene Therapy Targeting 14-3-3θ-TDP-43 Interaction | treats | drug | 0.88 |
| TDP-43 | biomarker_for | protein | 0.88 |
| Microglial Synapse Elimination | contributes_to | process | 0.85 |
| NPTX2 | biomarker_for | protein | 0.85 |
| Multisystem Proteinopathy | associated_with | disease | 0.85 |
| Reduced NPTX2 Concentrations | biomarker_for | biomarker | 0.85 |
| GSDME | associated_with | protein | 0.85 |
| Impaired Stress Granule Disassembly | associated_with | phenotype | 0.85 |
| Vesicle Trafficking | involved_in | process | 0.85 |
| Protein Deposition | contributes_to | process | 0.85 |
| Language Deficits | biomarker_for | phenotype | 0.85 |
| Behavioral Changes | biomarker_for | phenotype | 0.85 |
| Reducing Stress Granule Formation | contributes_to | process | 0.85 |
| Left Thalamus Hypoperfusion | biomarker_for | phenotype | 0.85 |
| Mutation Carriers | risk_factor_for | biomarker | 0.85 |
| Stress Granule Formation | protects_against | process | 0.85 |
| YWHAQ | mediates | protein | 0.85 |
| GGGGCC Hexanucleotide Repeat Expansion | biomarker_for | biomarker | 0.85 |
| Tau Aggregation Propagation | involved_in | process | 0.85 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||